APA Format 6, Peer Review & References From Walden Library

APA Format 6 Peer Review References 3 From Walden Library Please Pic

APA format 6 peer review references 3 from Walden Library. Please pick the topic Congestive Heart Failure or COPD from below list and follow instructions Assignment: Application: The Pathophysiology of Disorders In previous weeks, you explored various body systems: cardiovascular, respiratory, nervous, endocrine, musculoskeletal, gastrointestinal, and hematological. These seven systems work together, along with other body systems, to complete a myriad of functions. For this reason, when disorders occur within one body system, they can create potentially devastating effects throughout the entire body. For instance, Parkinson’s disease is a disorder of the central nervous system, yet its alterations actually affect multiple body systems, from the cardiovascular system to the gastrointestinal system.

In this Assignment, you examine alterations associated with disorders, as well as the impact of the alterations on multiple body systems. To prepare: From the list below, select a disorder of interest to you: Alzheimer’s disease, Asthma in children, Chronic obstructive pulmonary disease (COPD), Congestive heart failure, Hepatic disease (liver disease), Hypertension, Hyperthyroidism and hypothyroidism, Seizures, Sepsis. Reflect on alterations associated with the disorder you selected. Consider the pathophysiology of the alterations. Think about how these alterations produce pathophysiological changes in at least two body systems. Think about the types of drugs that would be used to treat alterations associated with the disorder you selected.

Reflect on how patient factors, such as genetics, gender, ethnicity, age, and behavior might impact the pathophysiology of the alterations you identified. Then, consider how these factors might impact the effects of prescribed drugs, as well as measures you might take to help reduce any negative side effects. Locate an agency that provides patient education on your selected disorder and review the available materials and curriculum. Consider how you might be able to use those materials to educate a patient on the disorder, treatment options, management, and self-care. By Day 7 Develop a 5- to 10-slide PowerPoint Presentation that addresses the following:; Describe the disorder you selected, as well as associated alterations.

Explain the pathophysiology of the alterations, including changes that occur in at least two body systems. Describe the types of drugs that would be prescribed to treat alterations associated with the disorder. Explain how genetics, gender, ethnicity, age, and behavior might impact the pathophysiology of the alterations you identified and the effects of prescribed drugs. Then, describe measures you might take to help reduce any negative side effects. Explain how you would use materials from a supporting agency to educate patients on the disorder, treatment options, management, and self-care. This assignment is due.

Paper For Above instruction

Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disorder characterized by airflow limitation that is not fully reversible. It encompasses conditions such as emphysema and chronic bronchitis and is primarily caused by long-term exposure to irritants, most notably tobacco smoke. COPD is a significant public health concern due to its high prevalence and morbidity, especially among older adults.

Pathophysiologically, COPD involves inflammatory responses within the airways and lung parenchyma, leading to structural changes such as airway narrowing, alveolar destruction, and mucous hypersecretion. These changes significantly impact multiple body systems, especially the respiratory system and the cardiovascular system.

In the respiratory system, airway inflammation results in obstructed airflow, impaired gas exchange, and reduced oxygenation. Patients often experience dyspnea, chronic cough, and sputum production. The destruction of alveoli decreases surface area for gas exchange, resulting in hypoxemia and hypercapnia. Consequently, these alterations lead to decreased oxygen delivery to tissues, affecting multiple organ systems.

The cardiovascular system is also profoundly affected in COPD, primarily through hypoxia-induced pulmonary vasoconstriction, leading to pulmonary hypertension. Over time, this strain can cause right-sided heart failure, also known as cor pulmonale. The chronic hypoxia and systemic inflammation associated with COPD can also contribute to atherosclerosis, with increased risks of myocardial infarction and stroke.

Pharmacologic management of COPD typically includes bronchodilators such as beta-agonists and anticholinergics to relieve airway obstruction. Corticosteroids are prescribed for exacerbations to reduce airway inflammation. Additionally, phosphodiesterase-4 inhibitors like roflumast contribute to reducing airway inflammation and mucus production.

Patient factors like genetics influence susceptibility to COPD, with mutations in genes related to alpha-1 antitrypsin deficiency increasing risk. Gender plays a role, as studies suggest women may experience more severe symptoms at similar levels of exposure. Ethnicity influences disease prevalence and response to therapy; for example, African American populations have higher exposure rates to environmental pollutants. Age impacts disease progression, with older adults more likely to present with advanced disease, and behavioral factors like smoking significantly exacerbate disease severity.

Understanding these factors is crucial for tailoring treatment and managing side effects. For example, pharmacogenomics can influence drug response, requiring personalized medicine approaches. Smoking cessation support and lifestyle modifications are essential to reduce disease progression and side effects of medications.

Educational materials from agencies like the American Lung Association provide valuable resources for patient education. These materials include information on the importance of medication adherence, oxygen therapy, pulmonary rehabilitation, and self-management strategies. Using these resources, healthcare providers can develop tailored education plans that include teaching proper inhaler techniques, recognizing exacerbation signs, and lifestyle modifications to improve quality of life.

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2023). Global strategy for the diagnosis, management, and prevention of COPD. Retrieved from https://goldcopd.org
  • Vestbo, J., et al. (2017). Global strategy for the diagnosis, management, and prevention of COPD: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 195(5), 557–582.
  • Sethi, S. (2019). COPD drugs: Pharmacology and clinical applications. Lung, 197(3), 175-183.
  • Cason, D., & Lucas, R. (2018). Impact of ethnicity and gender on COPD. Respiratory Care, 63(5), 670-678.
  • Barnett, K., et al. (2019). Genetic factors influencing COPD susceptibility. Journal of Genetic Medicine, 15(1), 20-30.
  • American Lung Association. (2022). COPD education and resources. Retrieved from https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd
  • Seemungal, T. A. R., et al. (2021). Pulmonary hypertension and COPD. Respiratory Medicine, 145, 106234.
  • Hurst, J. R., et al. (2019). The role of systemic inflammation in COPD. European Respiratory Journal, 55(1), 1801394.
  • Wedzicha, J. A., & Calverley, P. M. A. (2020). COPD exacerbations: Pathophysiology and management. Chest, 158(2), 302-319.

Related Assignments